Enhanced effect of neuropeptide Y on food intake caused by blockade of the V1A vasopressin receptor

European Journal of Pharmacology

Volumn 622, Issue 1-3, 2009, Pages 32-36

  Aoyagi, Toshinori ^a,b   Kusakawa, Shinji ^a   Sanbe, Atsushi ^a   Hiroyama, Masami ^a   Fujiwara, Yoko ^a   Yamauchi, Junji ^a   Tanoue, Akito ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Arginine vasopressin; Feeding behavior; Neuropeptide Y; V1A receptor

Indexed keywords

1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE; 1 [5 CHLORO 1 (2,4 DIMETHOXYLPHENYLSULFONYL) 2,3 DIHYDRO 3 (2 METHOXYPHENYL) 2 OXO 1H INDOL 3 YL] 4 HYDROXY N,N DIMETHYL 2 PYRROLIDINECARBOXAMIDE; ARGIPRESSIN; NEUROPEPTIDE Y; VASOPRESSIN V1A RECEPTOR;

ANIMAL EXPERIMENT; APPETITE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEEDING BEHAVIOR; FOOD INTAKE; HORMONE ACTION; MALE; MOUSE; NEUROMODULATION; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE;

ANIMALS; APPETITE; ARGININE VASOPRESSIN; EATING; FEEDING BEHAVIOR; MALE; MICE; MICE, INBRED C57BL; NEUROPEPTIDE Y; RECEPTORS, VASOPRESSIN;

EID: 70349987575     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.09.017     Document Type: Article

References (35)

1. Aoyagi T., Birumachi J., Hiroyama M., Fujiwara Y., Sanbe A., Yamauchi J., and Tanoue A. Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice. Endocrinology 148 (2007) 2075-2084
2. Aoyagi T., Izumi Y., Hiroyama M., Matsuzaki T., Yasuoka Y., Sanbe A., Miyazaki H., Fujiwara Y., Nakayama Y., Kohda Y., Yamauchi J., Inoue T., Kawahara K., Saito H., Tomita K., Nonoguchi H., and Tanoue A. Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells. Am. J. Physiol. Renal Physiol. 295 (2008) F100-F107
3. Arora S., and Anubhuti. Role of neuropeptides in appetite regulation and obesity - a review. Neuropeptides 40 (2006) 375-401
4. Decaux G., Soupart A., and Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 371 (2008) 1624-1632
5. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
6. Griebel G., Simiand J., Serradeil-Le Gal C., Wagnon J., Pascal M., Scatton B., Maffrand J.P., and Soubrie P. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 6370-6375
7. Hirasawa A., Hashimoto K., and Tsujimoto G. Distribution and developmental change of vasopressin V1a and V2 receptor mRNA in rats. Eur. J. Pharmacol. 267 (1994) 71-75
8. Hiroyama M., Aoyagi T., Fujiwara Y., Birumachi J., Shigematsu Y., Kiwaki K., Tasaki R., Endo F., and Tanoue A. Hypermetabolism of fat in V1a vasopressin receptor knockout mice. Mol. Endocrinol. 21 (2007) 247-258
9. Hiroyama M., Wang S., Aoyagi T., Oikawa R., Sanbe A., Takeo S., and Tanoue A. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice. Eur. J. Pharmacol. 559 (2007) 89-97
10. Ishizaki S., Murase T., Sugimura Y., Kakiya S., Yokoi H., Tachikawa K., Arima H., Miura Y., and Oiso Y. Role of ghrelin in the regulation of vasopressin release in conscious rats. Endocrinology 143 (2002) 1589-1593
11. Jackson, E.K., 1996. In Goodman & Gilman's the Pharmacological Basis of Therapeutics, eds. Hardman JG, Limbird LE, Gilman AG (McGraw-Hill, New York), 715-731.
12. Kakui K., and Kitamura K. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway. Endocrinology 148 (2007) 2854-2862
13. Kalsbeek A., La Fleur S., Van Heijningen C., and Buijs R.M. Suprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervations of the liver. J. Neurosci. 24 (2004) 7604-7613
14. Keyzer Y., Auzan C., Lenne F., Beldjord C., Thibonnier M., Bertagna X., and Clauser E. Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Lett. 356 (1994) 215-220
15. Kirk C.J., Rodrigues L.M., and Hems D.A. The influence of vasopressin and related peptides on glycogen phosphorylase activity and phosphatidylinositol metabolism in hepatocytes. Biochem. J. 178 (1979) 493-496
16. Leibowitz S.F., Sladek C., Spencer L., and Tempel D. Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose. Brain Res. Bull. 21 (1988) 905-912
17. Lolait S.J., O'Carroll A.M., McBride O.W., Konig M., Morel A., and Brownstein M.J. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357 (1992) 336-339
18. Marsh D.J., Hollopeter G., Kafer K.E., and Palmiter R.D. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat. Med. 4 (1998) 718-721
19. Mistry M.M., Swick A.G., and Romsos D.R. Leptin rapidly lowers food intake and elevates metabolic rates in lean and ob/ob mice. J. Nutr. 127 (1997) 2065-2072
20. Morel A., O'Carroll A.M., Brownstein M.J., and Lolait S.J. Molecular cloning and expression of a rat V1a arginine vasopressin receptor. Nature 356 (1992) 523-526
21. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kanagawa K., and Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 409 (2000) 194-198
22. Oomura Y., Ooyama H., Sugimori M., Nakamura T., and Yamada Y. Glucose inhibition of the glucose-sensitive neuron in the rat lateral hypothalamus. Nature 247 (1974) 284-286
23. Oshikawa S., Tanoue A., Koshimizu T., Kitagawa Y., and Tsujimoto G. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout. Mol. Pharmacol. 65 (2004) 623-629
24. Ostrowski N.L., Lolait S.J., Bardley D.J., O'Carroll A.M., Brownstein M.J., and Young W.S. Distribution of V1a and V2 vasopressin receptor messenger ribonucleic acids in rat liver, kidney, pituitary and brain. Endocrinology 131 (1992) 533-535
25. Ostrowski N.L., Lolait S.J., and Young W.S. Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature. Endocrinology 135 (1994) 1511-1528
26. Reymond-Marron I., Raggenbass M., and Zaninetti M. Vasopressin facilitates glycinergic and GABAergic synaptic transmission in developing hypoglossal motoneurons. Eur. J. NeuroSci. 21 (2005) 1601-1609
27. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., and Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptide and G protein coupled receptors that regulate feeding behavior. Cell 92 (1998) 573-585
28. Sanbe A., Takagi N., Fujiwara Y., Yamauchi J., Endo T., Mizutani R., Takeo S., Tsujimoto G., and Tanoue A. Alcohol preference in mice lacking the Avpr1a vasopressin receptor. Am. J. Physiol. 294 (2008) R1482-R1490
29. Sato I., Arima H., Ozaki N., Watanabe M., Goto M., Hayashi M., Banno R., Nagasaki H., and Oiso Y. Insulin inhibits neuropeptide Y gene expression in the arcuate nucleus through GABAergic systems. J. Neurosci. 25 (2005) 8657-8664
30. Serradeil-Le Gal C., Herbert J.M., Delisee C., Schaeffer P., Raufaste D., Garcia C., Dol F., Marty E., Maffrand J.P., and Le Fur G. Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells. Am. J. Physiol. 268 (1995) H404-H410
31. Shioda S., Takenoya F., Yagi M., Wang L., Hori Y., and Kagemiya H. Neural networks of several novel neuropeptides involved in feeding regulation. Nutrition 24 (2008) 848-853
32. Tsunematsu T., Fu L.Y., Yamanaka A., Ichiki K., Tanoue A., Sakurai T., and van den Pol A.N. Vasopressin increases locomotion through a V1a receptor in orexin/hypocretin neurons: implications for water homeostasis. J. Neurosci. 28 (2008) 228-238
33. Valassi E., Scacchi M., and Cavagnini F. Neuroednocrine control of food intake. Nutr. Metab. Cardiovasc. Dis. 18 (2008) 158-168
34. Willoughby J.O., and Blessing W.W. Neuropeptide Y injected into the supraoptic nucleus causes secretion of vasopressin in the unanaesthetized rat. Neurosci. Lett. 75 (1987) 17-22
35. Yamamura Y., Ogawa H., Chihara T., Kondo K., Onogawa T., Nakamura S., Mori T., Tominaga M., and Yabuuchi Y. OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist. Science 252 (1991) 572-574